The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quality of life in patients with gastroenteropancreatic neuroendocrine tumors receiving 177Lu-edotreotide or everolimus: Results from the COMPETE study.
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Esteve; Exelixis; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Roche/Genentech; Sanofi
Speakers' Bureau - Bayer; Eisai; Esteve; Hutchison MediPharma; Ipsen; Isotopen Technologien; Lilly; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Gilead Sciences (Inst); Ipsen (Inst); Ipsen (Inst); ITM Solucin (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Eisai; Gilead Sciences; Ipsen; Novartis; Novartis; Novartis; Pfizer
 
Henning Jann
Research Funding - Esteve; Ipsen; Novartis
Patents, Royalties, Other Intellectual Property - Elsevier
Travel, Accommodations, Expenses - Ipsen
 
Hein Verberne
No Relationships to Disclose
 
Jaroslaw Cwikla
Honoraria - Ipsen; Novartis
Consulting or Advisory Role - Ipsen; Novartis
Travel, Accommodations, Expenses - Ipsen; ITM Isotope Technologies Munich
 
Raj Srirajaskanthan
Honoraria - Advanz Pharma; Esteve; Ipsen; ITM Isotope Technologies Munich; Novartis; TERUMO
Research Funding - Novartis
Travel, Accommodations, Expenses - Ipsen; Novartis
Other Relationship - ITM Isotope Technologies Munich
 
Chiara Grana
Honoraria - ITM Isotope Technologies Munich
Consulting or Advisory Role - ITM Isotope Technologies Munich; Novartis
Research Funding - AIFA
Travel, Accommodations, Expenses - ITM Isotope Technologies Munich; Novartis
Other Relationship - ITANET
 
Michael Michael
Honoraria - Astellas Pharma; Ipsen
Consulting or Advisory Role - Astellas Australia; Bristol-Myers Squibb; Ipsen
Other Relationship - Spago
 
Jonathan Strosberg
Consulting or Advisory Role - Boehringer Ingelheim; Curium Pharma; Exelixis; Merck; Sanofi
Research Funding - Alphamedix (Inst); ITM Solucin (Inst); Novartis (Inst); RayzeBio (Inst)
 
Attila Kollar
Consulting or Advisory Role - Deciphera; Merck
Travel, Accommodations, Expenses - Amgen; Lilly; PharmaMar
 
Mike Sathekge
Leadership - Adcock Ingram; Africa Health Research Institute
Honoraria - Elsevier
Consulting or Advisory Role - NTP Radioistopes
Speakers' Bureau - Aktis; GE Healthcare
Research Funding - Alpha-9 Theranostics (Inst); AstraZeneca (Inst); Lilly (Inst); Molecular Partners (Inst); Novartis (Inst); Tellix - Rhino (Inst)
Travel, Accommodations, Expenses - Aktis (Inst); GE Healthcare; United
 
Catherine Ansquer
Honoraria - Advanced Accelerator Applications; Novartis
Consulting or Advisory Role - Advanced Accelerator Applications
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Novartis
 
Emmanuel Deshayes
Honoraria - Novartis
Consulting or Advisory Role - Ipsen; Novartis
Research Funding - ITM Isotope Technologies Munich (Inst); Lantheus Medical Imaging (Inst); Novartis (Inst); RayzeBio (Inst)
Travel, Accommodations, Expenses - GE Healthcare (Inst); Novartis
 
Rocio Garcia-Carbonero
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Pharma; AstraZeneca (I); Bayer; BMS; Boehringer Ingelheim; Crinetics Pharmaceuticals; Esteve; Gilead Sciences (I); GlaxoSmithKline; Hutchmed; Ipsen; Isotopen Technologien; Lilly (I); Merck; Mirati Therapeutics (I); MSD; Novocure; Pfizer (I); PharmaMar; Roche (I); Sanofi; Servier; Takeda
Research Funding - BMS (Inst); MSD (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Advanced Accelerator Applications/Novartis; Esteve; Ipsen; Merck; MSD
 
Alex Teulé
Speakers' Bureau - Advanced Accelerator Applications; Esteve; Novartis
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Advanz Pharma; Esteve; Novartis
 
Louis de Mestier
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; Boehringer Ingelheim; Esteve; Ipsen; Mayoly; Novartis; SERVIER; Viatris
Research Funding - Advanced Accelerator Applications; Boehringer Ingelheim; Ipsen; Novartis
Travel, Accommodations, Expenses - Advanced Accelerator Applications; Ipsen; Mayoly; Novartis
 
Serhii Melnyk
Employment - ITM Oncologics
Stock and Other Ownership Interests - Isotopen Technologien
 
Veronika Smutna
Employment - ITM Oncologics
Stock and Other Ownership Interests - Isotopen Technologien
 
Richardus Vonk
Employment - Bayer; ITM Oncologics
Stock and Other Ownership Interests - Bayer; ITM Isotope Technologies Munich
Consulting or Advisory Role - Verisian
 
Thomas Walter
Honoraria - Bristol Myers Squibb Foundation; IPSEN; ITM Oncologics; MSD Oncology; Novartis; OranoMed-SANOFI; Pierre Fabre; TERUMO
Consulting or Advisory Role - Advanced Accelerator Applications; ITM Isotope Technologies Munich; Orano Med; Sirtex Medical; TERUMO
Travel, Accommodations, Expenses - IPSEN; Novartis